FDCPs: generally BE (higher BA under certain conditions) [Regulatives / Guidelines]

posted by Mauricio Sampaio  – Brazil, 2016-05-19 07:47 (3190 d 23:04 ago) – Posting: # 16331
Views: 3,043

Thinking about a new Fixed Dose combination of two inhalers drugs in a same capsule, should be conducted tests to elucidate any pharmacokinetic or pharmacodynamic interaction between the actives as well as?

Until the moment, I was thinking that all interactions studies are used to predict interactions in drugs administrated by oral which metabolic effects can be observed.

:confused::confused::confused::confused:

Complete thread:

UA Flag
Activity
 Admin contact
23,380 posts in 4,914 threads, 1,662 registered users;
24 visitors (0 registered, 24 guests [including 3 identified bots]).
Forum time: 05:52 CET (Europe/Vienna)

Skill is a function of chance.
It’s an intuitive best-use of chance situations.    Philip K. Dick

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5